Skyrizi Pen - Side Effects, Interactions, Uses, Dosage, Warnings

Skyrizi Pen (Subcutaneous)

Skyrizi Pen (Subcutaneous)

Risankizumab is used alone or in combination in adults to treat moderate to severe plaque psoriasis and active psoriatic arthritis.

Risankizumab is also used in adults to treat Crohn's disease.

Risankizumab may also be used for purposes not listed in this medication guide.

warnings

What is the most important information I should know about Skyrizi Pen (Subcutaneous)?

You should not use risankizumab if you are allergic to it.

Before you start using risankizumab, tell your doctor if you have any signs of infection such as fever, chills, cough, body aches, tiredness, open sores, or skin wounds, diarrhea, stomach pain, weight loss, painful urination, or coughing up blood.

Tell your doctor if you have or ever had:

  • an active, chronic, or recent infection;
  • tuberculosis, been exposed to tuberculosis, or if you recently traveled;
  • recently received or are scheduled to receive any vaccine; or
  • liver disease.

Make sure you are current on all vaccines before you start using risankizumab.

If you are pregnant, your name may be listed on a pregnancy registry to track the effects of risankizumab on the baby.

It is not known if risankizumab will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

Ask a doctor if it is safe to breastfeed while using this medicine.

User Reviews & Rating

No ratings yet for Skyrizi Pen (Subcutaneous)

Leave a Review

Side Effects

What are the side effects of Skyrizi Pen (Subcutaneous)?

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

You may get infections more easily, even serious or fatal infections. Call your doctor right away if you have signs of infection such as:

  • fever, night sweats, chills, sore throat;
  • mouth sores, red or swollen gums;
  • pale skin, easy bruising, unusual bleeding; or
  • chest discomfort, wheezing, dry cough or hack, rapid weight loss.

Also call your doctor at once if you have:

  • nausea, vomiting, skin rash; or
  • liver problems--loss of appetite, stomach pain (upper right side), tiredness, itching, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).

Your treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects may include:

  • fever, headache, tiredness;
  • stomach pain, joint pain, back pain;
  • cold symptoms such as stuffy nose, sneezing, sore throat;
  • pain and burning when you urinate;
  • fungal skin infection;
  • low red blood cells (anemia); or
  • pain, bruising, swelling, or irritation where the medicine was injected.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Pregnancy & Breastfeeding

Can I take Skyrizi Pen (Subcutaneous) if I’m pregnant or breastfeeding?

If you are pregnant, your name may be listed on a pregnancy registry to track the effects of risankizumab on the baby.

It is not known if risankizumab will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

Ask a doctor if it is safe to breastfeed while using this medicine.

Interactions

What drugs and food should I avoid while taking Skyrizi Pen (Subcutaneous)?

Avoid receiving a "live" vaccine, or you could develop a serious infection. Live vaccines include measles, mumps, rubella (MMR), rotavirus, typhoid, yellow fever, varicella (chickenpox), and zoster (shingles).

Dosage Guidelines & Tips

How to take Skyrizi Pen (Subcutaneous)?

Use Skyrizi Pen (Subcutaneous) exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.

Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.

Before you use risankizumab, your doctor will test you for tuberculosis or other infections.

If you have Crohn's disease, risankizumab is given as an infusion into a vein by a healthcare provider every 4 weeks for the first 3 doses. Later doses are then injected under the skin once every 8 weeks.

If you have plaque psoriasis and psoriatic arthritis, risankizumab is injected under the skin every 4 weeks for the first 2 doses. Later doses are then injected every 12 weeks.

A healthcare provider may give you this injection or teach you how to properly use this medicine by yourself. Ask your doctor or pharmacist if you don't understand how to use a prefilled syringe, an injection pen, or the injector device placed on the body.

A full dose of risankizumab may require more than one injection under the skin. Your healthcare provider will show you where to inject risankizumab. Do not inject into the same place two times in a row. Avoid injecting into skin that is hard, red, bruised, swollen, tender, or affected by psoriasis.

Prepare an injection only when you are ready to give it. Call your pharmacist if the medicine looks cloudy, has changed colors or has particles in it.

Each injection is for one use only. Throw away after one use, even if there is still medicine left inside. Place it in a puncture-proof "sharps" container and dispose of it following state or local laws. Keep out of the reach of children and pets.

Throw away any risankizumab that has been shaken, frozen, or damaged in any way.

You may get infections more easily, even serious or fatal infections. You will need frequent medical tests.

You will need frequent blood tests to check your liver function.

Take the medicine out of the refrigerator and follow the instructions to let it reach room temperature before using the medicine. Do not warm the medicine with hot water, sunlight, or a microwave.

Store the medicine in the original container in the refrigerator. Protect from light and do not freeze.

Call your doctor for instructions if you miss an appointment for your risankizumab infusion.

Use the medicine as soon as you remember, and then go back to your regular schedule. Do not use two doses at one time.

Overdose Signs

What happens if I overdose on Skyrizi Pen (Subcutaneous)?

If you think you or someone else may have overdosed on: Skyrizi Pen (Subcutaneous),  call your doctor or the Poison Control center
(800) 222-1222
If someone collapses or isn't breathing after taking Skyrizi Pen (Subcutaneous), call 911
911

Medical Disclaimer

Drugs A-Z provides drug information from Everyday Health and our partners, as well as ratings from our members, all in one place. Cerner Multum™ provides the data within some of the Overview, Uses, Warnings, Side Effects, Pregnancy, Interactions, Dosage, Overdose, and Images sections. The information within all other sections is proprietary to Everyday Health.